EFEMP1 promoter methylation was detected in most primary PCa (96%), but only in a minority of non-cancerous prostate tissues (3% and 7%, for BPH and NPT respectively), as well as in 51% of HGPIN lesions. Here, EFEMP1 is linked to posterior cortical atrophy.